Bridging the Gap: Bioptimus CEO Jean-Philippe Vert on Building the Foundational AI for Biology

In this deep-dive episode of the Empowered Paient Podcast, Jean-Philippe explains why understanding biology across all scales—from molecules to organs—is the key to unlocking the next generation of precision medicine.

Bioptimus featured on the Empowered Patient Podcast

Our Co-Founder and CEO, Jean-Philippe Vert, sat down with Karen Jagoda to discuss how Bioptimus is moving beyond the "siloed" nature of traditional biomedical research. In this deep-dive episode, Jean-Philippe explains why understanding biology across all scales—from molecules to organs—is the key to unlocking the next generation of precision medicine.

A few highlights from the conversation:

  • The Problem of Silos: Historically, research has focused on specific layers, like genomics or cellular biology. Jean-Philippe discusses how Bioptimus is building an AI infrastructure that connects these dots to create a truly holistic view of human biology.
  • H-Optimus in Action: A look at our foundation model for histopathology, which helps pathologists analyze biopsies with unprecedented detail by learning from billions of images.
  • The Future of Clinical Trials: How "digital twins" and synthetic control arms can simulate treatment outcomes, lowering the cost of drug development and accelerating breakthroughs for rare diseases.
  • Closing the Translational Gap: Why a unified AI model is the essential tool for moving discoveries from the lab to the patient more efficiently.
"What we are building at Bioptimus is an AI-intelligent system that can see across all these layers to get a holistic picture of biology. It’s not only a scientific endeavor; it’s about solving why so many diseases remain untreated today."Jean-Philippe Vert

More like this: